Yuichi Hirose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuichi Hirose has a total of 238 co-authors. Here are the top co-authors by number of shared publications:
- Shigeo Ohba
Department of Neurosurgery, Fujita Health University School of Medicine, Toyoake, Japan
13 shared publications - Joji Inamasu
Department of Neurosurgery, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan
10 shared publications - Kazuhide Adachi
Fujita Health University
9 shared publications Mitsuhiro Hasegawa
From the Department of Neurosurgery (K.Y., M.H.), Fujita Health University Okazaki Medical Center, Okazaki, Aichi, Japan; Department of Neurosurgery (K.A., Y.H.), Fujita Health University, Toyoake, Aichi, Japan; Tokyo D-tower Hospital (M.H.), Tokyo, Japan
9 shared publicationsYuya Nishiyama
Department of Neurosurgery, Fujita Health University, Toyoake, Aichi 4701192, Japan
8 shared publications- Kei Yamashiro
Department of Neurosurgery, Fukuoka University, Fukuoka, Japan
7 shared publications
Latest Publications
- Open Access
- 18 October 2026
- Published by Wiley in Cancer Science
Distinct Clinicogenomic Contexts of BRAF ‐Altered Gliomas and Glioneuronal Tumors: A Nationwide Real‐World Study
BRAF alterations occur across diverse gliomas and glioneuronal tumors, but their alteration‐specific clinicogenomic contexts in real‐world cancer genomic profiling cohorts remain incompletely characterized. We analyzed BRAF ‐altered brain tumors registered in the Japanese Center for Cancer Genomics and Advanced Therapeutics database from June 2019 to March 2026. Operational diagnostic harmonization was performed using available clinicopathological and genomic information. Grade‐stratified analyses focused on BRAF p.V600E‐positive gliomas and glioneuronal tumors. Among 413 BRAF ‐altered brain tumors, 344 were classified as gliomas and glioneuronal tumors after harmonization. Within this cohort, the major alteration contexts included BRAF p.V600E‐positive tumors ( n = 166), KIAA1549 :: BRAF fusion‐positive tumors ( n = 60), amplification‐only tumors ( n = 15), and tumors with other BRAF alterations ( n = 109), with overlap in a subset. KIAA1549 :: BRAF fusion‐positive tumors were mainly associated with low‐grade glioma contexts, particularly pilocytic astrocytoma. Amplification‐only tumors showed marked enrichment of MET alterations, all representing MET amplification, together with frequent EGFR and TP53 co‐alterations, supporting a receptor tyrosine kinase‐amplified, copy‐number‐rich context. Among 118 grade‐evaluable BRAF p.V600E‐positive gliomas and glioneuronal tumors, CDKN2A/B homozygous deletion and TP53 / ATRX alterations were enriched in higher‐grade groups, and high‐grade tumors showed increased tumor mutational burden, although hypermutator phenotypes were rare. BRAF alteration classes define distinct clinicogenomic contexts in gliomas and glioneuronal tumors. These findings highlight both the opportunities and methodological challenges of nationwide real‐world cancer genomic profiling datasets in central nervous system tumor research.
- 18 October 2026
- Published by Wiley in Cancer Science
Open AccessDistinct Clinicogenomic Contexts of BRAF ‐Altered Gliomas and Glioneuronal Tumors: A Nationwide Real‐World Study
BRAF alterations occur across diverse gliomas and glioneuronal tumors, but their alteration‐specific clinicogenomic contexts in real‐world cancer genomic profiling cohorts remain incompletely characterized. We analyzed BRAF ‐altered brain tumors registered in the Japanese Center for Cancer Genomics and Advanced Therapeutics database from June 2019 to March 2026. Operational diagnostic harmonization was performed using available clinicopathological and genomic information. Grade‐stratified analyses focused on BRAF p.V600E‐positive gliomas and glioneuronal tumors. Among 413 BRAF ‐altered brain tumors, 344 were classified as gliomas and glioneuronal tumors after harmonization. Within this cohort, the major alteration contexts included BRAF p.V600E‐positive tumors ( n = 166), KIAA1549 :: BRAF fusion‐positive tumors ( n = 60), amplification‐only tumors ( n = 15), and tumors with other BRAF alterations ( n = 109), with overlap in a subset. KIAA1549 :: BRAF fusion‐positive tumors were mainly associated with low‐grade glioma contexts, particularly pilocytic astrocytoma. Amplification‐only tumors showed marked enrichment of MET alterations, all representing MET amplification, together with frequent EGFR and TP53 co‐alterations, supporting a receptor tyrosine kinase‐amplified, copy‐number‐rich context. Among 118 grade‐evaluable BRAF p.V600E‐positive gliomas and glioneuronal tumors, CDKN2A/B homozygous deletion and TP53 / ATRX alterations were enriched in higher‐grade groups, and high‐grade tumors showed increased tumor mutational burden, although hypermutator phenotypes were rare. BRAF alteration classes define distinct clinicogenomic contexts in gliomas and glioneuronal tumors. These findings highlight both the opportunities and methodological challenges of nationwide real‐world cancer genomic profiling datasets in central nervous system tumor research.
- Open Access
- 8 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216
Letter to the Editor Regarding “Intraoperative Fluorescence and Surgical Outcomes in Endoscopic Resection of Nonfunctioning Pituitary Macroadenomas: A Pilot Randomized Study”
- 8 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216
Open AccessLetter to the Editor Regarding “Intraoperative Fluorescence and Surgical Outcomes in Endoscopic Resection of Nonfunctioning Pituitary Macroadenomas: A Pilot Randomized Study”
- Open Access
- 18 September 2026
- Published by Springer Nature in Acta Neurochirurgica
Comparative prognostic value of CT-derived temporal muscle parameters in chronic subdural hematoma: a retrospective cohort study
- 18 September 2026
- Published by Springer Nature in Acta Neurochirurgica
Open AccessComparative prognostic value of CT-derived temporal muscle parameters in chronic subdural hematoma: a retrospective cohort study
- Open Access
- 24 July 2026
- Published by Elsevier in World Neurosurgery
- Vol. 213
Robot-Assisted Transoral Trans-hard Palate Corridor to the Ventral Skull Base: A Cadaveric Feasibility Study
- 24 July 2026
- Published by Elsevier in World Neurosurgery
- Vol. 213
Open AccessRobot-Assisted Transoral Trans-hard Palate Corridor to the Ventral Skull Base: A Cadaveric Feasibility Study
- 2 March 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 265, 109371
Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective series
- 2 March 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 265, 109371
Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective series
- Open Access
- 20 June 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (5) , 1453-1458
High-resolution CT angiography for follow-up evaluation of intracranial aneurysms treated with the Woven EndoBridge device: comparison with digital subtraction angiography
Purpose Digital subtraction angiography (DSA) is the gold standard for follow-up evaluation of intracranial aneurysms treated with the Woven EndoBridge (WEB) device. This study aimed to assess the efficacy of high-resolution CT angiography (HR-CTA) as a less invasive alternative by comparing its diagnostic performance with that of DSA. Methods This single-center retrospective study analyzed the angiographic and clinical data of patients treated with the WEB device for cerebral aneurysms between January 2021 and December 2024. Patients who underwent HR-CTA within 2 weeks before or after follow-up DSA were included. Occlusion status was assessed using the Bicêtre Occlusion Scale Score (BOSS) and binary classification. The concordance rate between HR-CTA and DSA was evaluated. Results A total of 54 eligible examinations were identified. Using the BOSS, 46 examinations were concordant, resulting in an agreement rate of 85.2%. The Cohen’s κ coefficient was 0.81 (95% CI 0.69 to 0.93), indicating a very high level of agreement. All discordant cases resulted from HR-CTA overestimating occlusion status; however, HR-CTA accurately identified aneurysm remnants. Univariate analyses identified BOSS 0’ as the only significant factor contributing to discrepancies. In the binary evaluation, all 54 examinations were fully concordant (κ=1.00, 95% CI 1.00 to 1.00). Conclusions HR-CTA demonstrated a high concordance rate with DSA for evaluating occlusion status after WEB placement. Its reliable assessment of aneurysm remnants suggests HR-CTA could serve as a practical and less invasive alternative to DSA in follow-up evaluations.
- 20 June 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (5) , 1453-1458
Open AccessHigh-resolution CT angiography for follow-up evaluation of intracranial aneurysms treated with the Woven EndoBridge device: comparison with digital subtraction angiography
Purpose Digital subtraction angiography (DSA) is the gold standard for follow-up evaluation of intracranial aneurysms treated with the Woven EndoBridge (WEB) device. This study aimed to assess the efficacy of high-resolution CT angiography (HR-CTA) as a less invasive alternative by comparing its diagnostic performance with that of DSA. Methods This single-center retrospective study analyzed the angiographic and clinical data of patients treated with the WEB device for cerebral aneurysms between January 2021 and December 2024. Patients who underwent HR-CTA within 2 weeks before or after follow-up DSA were included. Occlusion status was assessed using the Bicêtre Occlusion Scale Score (BOSS) and binary classification. The concordance rate between HR-CTA and DSA was evaluated. Results A total of 54 eligible examinations were identified. Using the BOSS, 46 examinations were concordant, resulting in an agreement rate of 85.2%. The Cohen’s κ coefficient was 0.81 (95% CI 0.69 to 0.93), indicating a very high level of agreement. All discordant cases resulted from HR-CTA overestimating occlusion status; however, HR-CTA accurately identified aneurysm remnants. Univariate analyses identified BOSS 0’ as the only significant factor contributing to discrepancies. In the binary evaluation, all 54 examinations were fully concordant (κ=1.00, 95% CI 1.00 to 1.00). Conclusions HR-CTA demonstrated a high concordance rate with DSA for evaluating occlusion status after WEB placement. Its reliable assessment of aneurysm remnants suggests HR-CTA could serve as a practical and less invasive alternative to DSA in follow-up evaluations.
- Open Access
- 31 March 2024
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 21 (1) , 106-115
Transoral Robotic-Assisted Neurosurgery for Skull Base and Upper Spine Lesions
Objective: The application of the da Vinci Surgical System in neurosurgery is limited due to technical difficulties requiring precise maneuvers and small instruments. This study details the advantages and disadvantages of robotics in neurosurgery and the reachable range of the transoral approach to lesions of the skull base and upper cervical spine.Methods: In a cadaver study, the da Vinci Xi robot, lacking haptic feedback, was utilized for sagittal and coronal approaches on 5 heads, facilitating dura suturing in 3, with a 30°-angled drill for bone removal.Results: Perfect exposure of all the nasopharyngeal sites, clivus, sellar, and choana, including the bilateral eustachian tubes, was achieved without any external incisions using this palatal split approach of transoral robotic surgery. The time required to perform a single stitch, knot, and complete single suture in robotic suturing of deep-seated were significantly less compared to manual suturing via the endonasal approach.Conclusion: This is the first report to show the feasibility of suturing the dural defect in deep-seated lesions transorally and revealed that the limit of reach in the coronal plane via a transoral approach with incision of the soft palate is the foramen ovale. This preclinical investigation also showed that the transoral robotic approach is feasible for lesions extending from the sellar to the C2 in the sagittal plane. Refinement of robotic instruments for specific anatomic sites and future neurosurgical studies are needed to further demonstrate the feasibility and effectiveness of this system in treating benign and malignant skull base lesions.
- 31 March 2024
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 21 (1) , 106-115
Open AccessTransoral Robotic-Assisted Neurosurgery for Skull Base and Upper Spine Lesions
Objective: The application of the da Vinci Surgical System in neurosurgery is limited due to technical difficulties requiring precise maneuvers and small instruments. This study details the advantages and disadvantages of robotics in neurosurgery and the reachable range of the transoral approach to lesions of the skull base and upper cervical spine.Methods: In a cadaver study, the da Vinci Xi robot, lacking haptic feedback, was utilized for sagittal and coronal approaches on 5 heads, facilitating dura suturing in 3, with a 30°-angled drill for bone removal.Results: Perfect exposure of all the nasopharyngeal sites, clivus, sellar, and choana, including the bilateral eustachian tubes, was achieved without any external incisions using this palatal split approach of transoral robotic surgery. The time required to perform a single stitch, knot, and complete single suture in robotic suturing of deep-seated were significantly less compared to manual suturing via the endonasal approach.Conclusion: This is the first report to show the feasibility of suturing the dural defect in deep-seated lesions transorally and revealed that the limit of reach in the coronal plane via a transoral approach with incision of the soft palate is the foramen ovale. This preclinical investigation also showed that the transoral robotic approach is feasible for lesions extending from the sellar to the C2 in the sagittal plane. Refinement of robotic instruments for specific anatomic sites and future neurosurgical studies are needed to further demonstrate the feasibility and effectiveness of this system in treating benign and malignant skull base lesions.
- Open Access
- 30 January 2024
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (5) , 618-625
Tumor Embolization via the Meningohypophyseal and Inferolateral Trunk in Patients with Skull Base Tumors Using the Distal Balloon Protection Technique
BACKGROUND AND PURPOSE: Tumor embolization through the meningohypophyseal trunk and inferolateral trunk is known to be effective in skull-based tumors; however, microcatheter cannulation into these arteries is difficult, and the number of cases that can be safely embolized is limited. In this study, we present a novel embolization procedure for meningohypophyseal trunk and inferolateral trunk using the distal balloon protection technique and detail its clinical efficacy and complication risks. We developed this procedure to allow safe embolization in patients who cannot be adequately cannulated with microcatheters into these arteries. MATERIALS AND METHODS: Patients who underwent meningohypophyseal trunk or inferolateral trunk embolization using the distal balloon protection technique for skull-based tumors at our institution between 2010 and 2023 were included. In this procedure, the ICA was temporarily occluded with a balloon at the ophthalmic artery bifurcation, the microcatheter was guided to the meningohypophyseal trunk or inferolateral trunk vicinity, and embolic particles were injected into the arteries. The balloon was deflated after the embolic particles, that had refluxed into the ICA, were aspirated. RESULTS: A total of 25 meningohypophyseal trunks and inferolateral trunks were embolized during 21 surgeries. Of these 25 arteries, only nine (36.0%) were successfully cannulated with microcatheters. Nevertheless, effective embolization was achieved in all cases. Permanent complications occurred in only one case (4.8%), in which the central retinal artery was occluded during inferolateral trunk embolization, resulting in a visual field defect. No permanent complications resulting from the embolic cerebral infarction were observed. Of 16 cases that underwent MRI within a week after embolization, however, 11 (68.8%) demonstrated embolic cerebral infarctions. CONCLUSIONS: In patients with skull-based tumors with meningohypophyseal trunk or inferolateal trunk feeders that cannot be catheterized directly, embolization using the distal balloon protection technique for tumor supply can be considered as a salvage technique. ABBREVIATIONS: MHT = meningohypophyseal trunk; ILT = inferolateral trunk; GC = guide catheter; AC = aspiration catheter; FR = flow reverse
- 30 January 2024
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (5) , 618-625
Open AccessTumor Embolization via the Meningohypophyseal and Inferolateral Trunk in Patients with Skull Base Tumors Using the Distal Balloon Protection Technique
BACKGROUND AND PURPOSE: Tumor embolization through the meningohypophyseal trunk and inferolateral trunk is known to be effective in skull-based tumors; however, microcatheter cannulation into these arteries is difficult, and the number of cases that can be safely embolized is limited. In this study, we present a novel embolization procedure for meningohypophyseal trunk and inferolateral trunk using the distal balloon protection technique and detail its clinical efficacy and complication risks. We developed this procedure to allow safe embolization in patients who cannot be adequately cannulated with microcatheters into these arteries. MATERIALS AND METHODS: Patients who underwent meningohypophyseal trunk or inferolateral trunk embolization using the distal balloon protection technique for skull-based tumors at our institution between 2010 and 2023 were included. In this procedure, the ICA was temporarily occluded with a balloon at the ophthalmic artery bifurcation, the microcatheter was guided to the meningohypophyseal trunk or inferolateral trunk vicinity, and embolic particles were injected into the arteries. The balloon was deflated after the embolic particles, that had refluxed into the ICA, were aspirated. RESULTS: A total of 25 meningohypophyseal trunks and inferolateral trunks were embolized during 21 surgeries. Of these 25 arteries, only nine (36.0%) were successfully cannulated with microcatheters. Nevertheless, effective embolization was achieved in all cases. Permanent complications occurred in only one case (4.8%), in which the central retinal artery was occluded during inferolateral trunk embolization, resulting in a visual field defect. No permanent complications resulting from the embolic cerebral infarction were observed. Of 16 cases that underwent MRI within a week after embolization, however, 11 (68.8%) demonstrated embolic cerebral infarctions. CONCLUSIONS: In patients with skull-based tumors with meningohypophyseal trunk or inferolateal trunk feeders that cannot be catheterized directly, embolization using the distal balloon protection technique for tumor supply can be considered as a salvage technique. ABBREVIATIONS: MHT = meningohypophyseal trunk; ILT = inferolateral trunk; GC = guide catheter; AC = aspiration catheter; FR = flow reverse
- 6 January 2024
- Published by Elsevier in World Neurosurgery
- Vol. 183, e707-e714
Role of a Tortuous Vertebrobasilar Artery and Anchoring Perforators in the Etiology of Hemifacial Spasm
- 6 January 2024
- Published by Elsevier in World Neurosurgery
- Vol. 183, e707-e714
Role of a Tortuous Vertebrobasilar Artery and Anchoring Perforators in the Etiology of Hemifacial Spasm